1. The Small Molecule H89 Inhibits Chlamydia Inclusion Growth and Production of Infectious Progeny
- Author
-
Kevin Wang, Karissa J Muñoz, Christine Sütterlin, Ming Tan, and Lauren M. Sheehan
- Subjects
Chlamydia ,Kinase ,Immunology ,Biology ,Golgi apparatus ,medicine.disease ,Microbiology ,Cell biology ,Vesicular transport protein ,symbols.namesake ,Infectious Diseases ,medicine ,symbols ,Parasitology ,Protein kinase A ,Pathogen ,Lipid Transport ,Intracellular - Abstract
Chlamydia is an obligate intracellular bacterium and the most common reportable cause of human infection in the United States. This pathogen proliferates inside a eukaryotic host cell, where it resides within a membrane-bound compartment called the chlamydial inclusion. It has an unusual developmental cycle, marked by conversion between a replicating form, the reticulate body (RB), and an infectious form, the elementary body (EB). We found that the small molecule H89 slowed inclusion growth and decreased overall RB replication by 2-fold but caused a 25-fold reduction in infectious EBs. This disproportionate effect on EB production was mainly due to a defect in RB-to-EB conversion and not to the induction of chlamydial persistence, which is an altered growth state. Although H89 is a known inhibitor of specific protein kinases and vesicular transport to and from the Golgi apparatus, it did not cause these anti-chlamydial effects by blocking protein kinase A or C or by inhibiting protein or lipid transport. Thus, H89 is a novel anti-chlamydial compound that has a unique combination of effects on an intracellular Chlamydia infection.
- Published
- 2021
- Full Text
- View/download PDF